658 results found

Food-pharma industry convergence is not a new development. In 2013, a study of the patent citation data of 274 published European patents by 5 EU Medical Nutrition companies revealed the...

The caterpillar war may have been settled last year, but it hasn't stopped Aldi continuing to dig at M&S.

Being a Chartered Trade Mark Attorney can be hard to explain, but how can you get into this rewarding profession? We asked HGF's Director of Trade Marks Lauren Somers to explain her path.

Episodes 21-30 of the Fashionably IP Podcast where we will be looking at important hot topics in the world of fashion and intellectual property.

Episodes 31-40 of the Fashionably IP Podcast where we will be looking at important hot topics in the world of fashion and intellectual property. We will be focusing on key aspects of design protection in the UK and EU.

Intellectual property diligence too often starts with the wrong question: how many patents does the company have? For venture investors, that is rarely the most revealing answer. The real issue is whether the founders understand IP as a strategic asset — something that protects ownership, supports freedom to operate, strengthens the commercial moat and increases the company’s value before the next funding round.

Can we find a balance between intellectual property rights and public health needs when tackling the climate crisis?

The shift from fossil fuels to greener energy will profoundly impact the profitability of many businesses in the energy sector. However, innovation has become an essential facilitator...

As the saying goes, "We eat first with our eyes". The visual appearance, especially the colour, of a food or beverage product is one of the first things...

Using SleepCogni as a case study, we look at some key ways that IP can help start-ups to develop their technology and secure investment. SleepCogni is a SleepTech start-up who have developed...

This case concerned Amgen's European patent no. 2962690 for apremilast, a drug sold under the brand name Otezla®, licensed for the treatment of e.g., psoriasis and psoriatic arthritis.

The Innovative Devices Access Pathway has recently launched in the UK. This scheme is set to create opportunities for real-world data collection, enhancing the value proposition of products...

Greater Manchester has committed to become a zero carbon city by 2038. The race to decarbonise the local economy and replace existing technologies used in our city with sustainable and green technologies will require innovation.

The Milan Local Division granted a defendant's request for an extension until 14 days after the hearing and expected decision of the EPO's Board of Appeal in respect of the same Patent.

The UPC Court of Appeal upheld a decision denying Alexion preliminary injunctions against Samsung Bioepis and Amgen over the patent for its Soliris® drug. The court found the patent's error in the antibody sequence not sufficiently certain for correction, aligning with the EPO's Technical Board of Appeal's stance.

After an interim High Court decision and a Court of Appeals decision, Mrs Justice J. Smith handed down her judgement on 19 April in favour of Lidl having held...

The Court of Justice of the European Union (‘the Court of Justice’) handed down its keenly anticipated decision on the use of trade marks in keyword advertising campaigns on the 22nd September 2011.